Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001559053-26-000022
Filing Date
2026-08-06
Accepted
2026-08-06 16:20:08
Documents
69
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prta-20260630.htm   iXBRL 10-Q 1387509
2 EX-31.1 prta2026q210-qxex311.htm EX-31.1 10920
3 EX-31.2 prta2026q210-qxex312.htm EX-31.2 11033
4 EX-32.1 prta2026q210-qxex321.htm EX-32.1 8984
  Complete submission text file 0001559053-26-000022.txt   7407930

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20260630.xsd EX-101.SCH 75786
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20260630_cal.xml EX-101.CAL 79317
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20260630_def.xml EX-101.DEF 335808
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20260630_lab.xml EX-101.LAB 801455
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20260630_pre.xml EX-101.PRE 534319
73 EXTRACTED XBRL INSTANCE DOCUMENT prta-20260630_htm.xml XML 832328
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 261249442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)